Cargando…

Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults

Detalles Bibliográficos
Autor principal:	King-Stephens, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Current Literature in Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549228/ https://www.ncbi.nlm.nih.gov/pubmed/36285199 http://dx.doi.org/10.1177/15357597221107796

Ejemplares similares

Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma
por: Alzial, Gabriel, et al.
Publicado: (2021)

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
por: Gittleman, Haley, et al.
Publicado: (2019)

Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma
por: Wang, Shouchao, et al.
Publicado: (2022)

Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation
por: Ehret, Felix, et al.
Publicado: (2023)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

SANAD II: Dear Levetiracetam, the Honeymoon Is Over
por: Bermeo-Ovalle, Adriana
Publicado: (2021)

Genetic Mechanisms Behind Severe Psychotic Reactions to Levetiracetam
por: Andrade, Danielle M.
Publicado: (2022)

A Case of Glioblastoma, Isocitrate Dehydrogenase Wild Type, With Widely Disseminated Osseous Metastasis
por: Conte, Brianna, et al.
Publicado: (2022)

Levetiracetam in Alzheimer’s Disease: Do Epileptologists Already Have the Cure?
por: Sarkis, Rani A.
Publicado: (2022)

Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2023)

Be a PEACH and Hand Me That Levetiracetam: Seizure Prophylaxis for Spontaneous Intracerebral Hemorrhage
por: Cervenka, Mackenzie C.
Publicado: (2023)

The T2-FLAIR mismatch sign in glioblastoma, isocitrate dehydrogenase wild-type A case report
por: Nishimura, Shunsuke, et al.
Publicado: (2023)

Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus
por: Vossler, David G.
Publicado: (2019)

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
por: Oh, Sejin, et al.
Publicado: (2020)

Preoperative Predictors of Early Mortality Risk in Isocitrate Dehydrogenase-Wild-Type Glioblastoma Patients Treated with Standard Therapy
por: Zhao, Chao, et al.
Publicado: (2021)

TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma
por: Gao, Mengqi, et al.
Publicado: (2021)

Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas
por: Hsieh, Kevin Li-Chun, et al.
Publicado: (2017)

Clinical implications of hypoxia-inducible factor-1α and caveolin-1 overexpression in isocitrate dehydrogenase-wild type glioblastoma multiforme
por: Chen, Wenli, et al.
Publicado: (2019)

Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

The Ambiguous Nature of Fast Ripples in Epilepsy Surgery
por: King-Stephens, David
Publicado: (2019)

The Value of Localizing Subclinical Seizures
por: King-Stephens, David
Publicado: (2020)

Do Interictal Rates Influence Treatment Outcomes in Temporal Lobe Epilepsy?
por: King-Stephens, David
Publicado: (2020)

Biomarkers for SUDEP: Are We There Yet?
por: King-Stephens, David
Publicado: (2019)

What Is the Best Target for Ablation of Mesial Temporal Lobe Epilepsy?
por: King-Stephens, David
Publicado: (2019)

Neuromodulation: The Search Is On for the Most Effective Parameters
por: King-Stephens, David
Publicado: (2020)

Is STN Neuromodulation of Focal Motor Seizures Ready for Prime Time?
por: King-Stephens, David
Publicado: (2021)

Cheers for SANTĖ: Long Term Safety and Efficacy of Anterior Nucleus of the Thalamus DBS
por: King-Stephens, David
Publicado: (2021)

Approximation Is Not Randomization; Lessons From Comparative Observational Studies of Invasive EEG Methods
por: King-Stephens, David
Publicado: (2022)

Deep-Seated Interictal Epileptiform Activity: Another Reason to Lose Sleep
por: King-Stephens, David
Publicado: (2020)

Is Node Disconnection the Key for Improving LITT Outcome?
por: King-Stephens, David
Publicado: (2022)

Nomograms Should Not Be Used by General Neurologists When Considering Referral for Epilepsy Surgery
por: King-Stephens, David
Publicado: (2022)

Old Diagnostic Meets Newer Therapy; ECoG During LiTT
por: King-Stephens, David
Publicado: (2023)

Seizures and Cardiac Dysrhythmias: And the Beat (Sometimes) Goes On
por: King-Stephens, David
Publicado: (2022)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Expression of Cathepsins B, D, and G in Isocitrate Dehydrogenase-Wildtype Glioblastoma
por: Koh, Sabrina P., et al.
Publicado: (2017)

Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas
por: Beyer, Sasha J., et al.
Publicado: (2018)

Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance
por: He, Qiwei, et al.
Publicado: (2022)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

Computer-aided diagnosis of isocitrate dehydrogenase genotypes in glioblastomas from radiomic patterns
por: Lo, Chung-Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_230rimb8md5nd3bl7s4ruvnvvo